WO2002036094A3 - Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes - Google Patents

Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes Download PDF

Info

Publication number
WO2002036094A3
WO2002036094A3 PCT/FR2001/003353 FR0103353W WO0236094A3 WO 2002036094 A3 WO2002036094 A3 WO 2002036094A3 FR 0103353 W FR0103353 W FR 0103353W WO 0236094 A3 WO0236094 A3 WO 0236094A3
Authority
WO
WIPO (PCT)
Prior art keywords
adhesion effect
dermatological
cells
cosmetic composition
circulating cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2001/003353
Other languages
English (en)
Other versions
WO2002036094A2 (fr
Inventor
Francine Joly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SEPHRA
Original Assignee
SEPHRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0013993A external-priority patent/FR2815872A1/fr
Application filed by SEPHRA filed Critical SEPHRA
Priority to AU2002215080A priority Critical patent/AU2002215080A1/en
Priority to EP01983642A priority patent/EP1330235A2/fr
Publication of WO2002036094A2 publication Critical patent/WO2002036094A2/fr
Publication of WO2002036094A3 publication Critical patent/WO2002036094A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention se rapporte au domaine de la chimie, et plus particulièrement au domaine de la cosmétique ou pharmaceutique, notamment dermatologique. Elle a plus particulièrement pour objet, un composition dermatologique et / ou cosmétique pour la mise en oeuvre d'un procédé de traitement de peaux sensibles et/ou réactives aux fumées, notamment aux fumées de tabac. La composition contient un principe actif composé de substances antagonisant l'effet d'adhésion, induit par lesdites fumées, des cellules circulantes humaines, notamment les neutrophiles, les lymphocytes, les monocytes, les éosinophiles, aux autres cellules ou molécules de la matrice extracellulaire, notamment avec des kératinocytes humains.Parmi les substances antagonisant ledit effet d'adhésion, l'invention concerne plus particulièrement des compositions ayant pour principe actif un pyrrolidone-2 carboxylate d'arginine, notamment le pyrrolidone-2 carboxylate L-arginine.La composition a des effets apaisants, anti-irritants, anti-inflammatoires et anti-vieillissement sur la peau.
PCT/FR2001/003353 2000-10-31 2001-10-26 Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes Ceased WO2002036094A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002215080A AU2002215080A1 (en) 2000-10-31 2001-10-26 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells
EP01983642A EP1330235A2 (fr) 2000-10-31 2001-10-26 Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0013993A FR2815872A1 (fr) 2000-10-31 2000-10-31 Nouvelles compositions cosmetiques et leur utilisation pour diminuer l'adhesion des granulocytes
FR00/13993 2000-10-31
FR0111643A FR2815866B1 (fr) 2000-10-31 2001-09-07 Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes
FR01/11643 2001-09-07

Publications (2)

Publication Number Publication Date
WO2002036094A2 WO2002036094A2 (fr) 2002-05-10
WO2002036094A3 true WO2002036094A3 (fr) 2002-08-08

Family

ID=26212709

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/003353 Ceased WO2002036094A2 (fr) 2000-10-31 2001-10-26 Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes

Country Status (4)

Country Link
EP (1) EP1330235A2 (fr)
AU (1) AU2002215080A1 (fr)
FR (1) FR2815866B1 (fr)
WO (1) WO2002036094A2 (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671020A (en) * 1979-11-15 1981-06-13 Shiseido Co Ltd Cosmetics
JPS5931706A (ja) * 1982-08-17 1984-02-20 Lion Corp 化粧料組成物
JPS6130509A (ja) * 1984-07-23 1986-02-12 Shiseido Co Ltd 皮膚外用剤
US4581371A (en) * 1982-03-18 1986-04-08 Laboratori Baldacci S.P.A. Pharmaceutical composition having immunomodulating activity
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
EP0511118A1 (fr) * 1991-04-24 1992-10-28 L'oreal Utilisation du pyrrolidone carboxylate de lysine et/ou d'arginine comme substance antioxydante dans une composition cosmétique ou pharmaceutique
WO1996028008A2 (fr) * 1996-03-19 1996-09-19 Guerlain S.A. Compositions cosmetiques et dermatologiques pour lutter contre le vieillissement de la peau
FR2778562A1 (fr) * 1998-05-14 1999-11-19 Sephra Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
EP0979644A1 (fr) * 1998-08-13 2000-02-16 Società Italo-Britannica L. Manetti-H. Roberts & C. S.p.A. Composition cosmétique déodorante ou hydratante

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671020A (en) * 1979-11-15 1981-06-13 Shiseido Co Ltd Cosmetics
US4581371A (en) * 1982-03-18 1986-04-08 Laboratori Baldacci S.P.A. Pharmaceutical composition having immunomodulating activity
JPS5931706A (ja) * 1982-08-17 1984-02-20 Lion Corp 化粧料組成物
JPS6130509A (ja) * 1984-07-23 1986-02-12 Shiseido Co Ltd 皮膚外用剤
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
EP0511118A1 (fr) * 1991-04-24 1992-10-28 L'oreal Utilisation du pyrrolidone carboxylate de lysine et/ou d'arginine comme substance antioxydante dans une composition cosmétique ou pharmaceutique
WO1996028008A2 (fr) * 1996-03-19 1996-09-19 Guerlain S.A. Compositions cosmetiques et dermatologiques pour lutter contre le vieillissement de la peau
FR2778562A1 (fr) * 1998-05-14 1999-11-19 Sephra Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
EP0979644A1 (fr) * 1998-08-13 2000-02-16 Società Italo-Britannica L. Manetti-H. Roberts & C. S.p.A. Composition cosmétique déodorante ou hydratante

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 005, no. 136 (C - 069) 28 August 1981 (1981-08-28) *
PATENT ABSTRACTS OF JAPAN vol. 008, no. 118 (C - 226) 31 May 1984 (1984-05-31) *
PATENT ABSTRACTS OF JAPAN vol. 010, no. 182 (C - 356) 25 June 1986 (1986-06-25) *

Also Published As

Publication number Publication date
WO2002036094A2 (fr) 2002-05-10
AU2002215080A1 (en) 2002-05-15
EP1330235A2 (fr) 2003-07-30
FR2815866B1 (fr) 2015-06-19
FR2815866A1 (fr) 2002-05-03

Similar Documents

Publication Publication Date Title
US7566464B2 (en) Cosmetic composition to accelerate repair of functional wrinkles
EP0738510A3 (fr) Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
CY1108934T1 (el) Τοπικες συνθεσεις οι οποιες συνδυαζουν κλασματα υαλουρονικου νατριου και ενα ρετινοειδες
WO2009090624A3 (fr) Gel de chitosane pour applications dermatologiques, procédé d'obtention et d'utilisation de celui-ci
WO2007029187A3 (fr) Utilisation de protoberberines comme substance active regulant l'unite pilosebacee
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
WO2008145692A3 (fr) Composition cosmétique comprenant un agent actif capable de stimuler l'expression de la tensine 1
WO2008122517A3 (fr) Compositions d'écran solaire et de soin de la personne comprenant un terpolymère aléatoire
EP1426030A4 (fr) Substances capables de potentialiser la productivite de la laminine 5 dans des cellules epidermiques et utilisation desdites substances
EP1938866A3 (fr) Produit cosmétique comprenant un produit extrait ovarien de Salmonidae
WO2000057836A3 (fr) Compositions cosmetiques ou dermatologiques contenant au moins une substance destinee a augmenter la fonctionnalite et/ou l'expression des recepteurs membranaires cd44 des cellules de la peau
ATE524486T1 (de) Lys-thr-dipeptide und deren verwendung
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
WO2007053647A3 (fr) Compositions cosmetiques de soins pour la peau utilisant des tubules derivant de mineraux pour une liberation controlee
EP1589984A4 (fr) Composition topique et procede permettant le traitement de la peau abimee par l'age ou les conditions d'existence
US20170042956A1 (en) Embelia concinna extract comprising flavonoids in cosmetic and pharmaceutical compositions
PT1809383E (pt) Composições cosméticas
WO2002036094A3 (fr) Procede et composition dermatologique et/ou cosmetique antagonisant l'effet d'adhesion des cellules circulantes
ATE228350T1 (de) Verwendung eines terminalia catappa extraktes
WO2025035004A3 (fr) Compositions cosmétiques et leurs procédés d'utilisation
WO2003070180A3 (fr) Compositions et procedes d'administration de cosmetiques pour la peau
WO2012001082A3 (fr) Composition hydratante présentant un fps de 30
PL2100592T3 (pl) Kosmetyk o działaniu przeciw starzeniu
Mellody et al. The skin extracellular matrix as a target of environmental exposure: molecular mechanisms, prevention and repair
WO2008009813A3 (fr) Utilisation d'un extrait de gleditsia en cosmétique et en dermatologie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001983642

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001983642

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001983642

Country of ref document: EP